¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"thyrotoxic complement-fixation factor"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
9
¿µ¹®
ÇѱÛ
radiation weighting factor
¹æ»ç¼±°¡Áß°è¼ö
resistance factor
³»¼ºÀÎÀÚ, ÀúÇ×ÀÎÀÚ
resistance transfer factor
³»¼ºÀü´ÞÀÎÀÚ
reticuloendothelial depressant factor
±×¹°³»Çǰè¾ïÁ¦ÀÎÀÚ, ¸Á»ó³»Çǰè¾ïÁ¦ÀÎÀÚ
rheumatoid factor
·ù¸¶Æ¼½ºÀÎÀÚ
risk factor
À§ÇèÀÎÀÚ
roentgen-to-rad conversion factor
·ÛÆ®°Õ´ë·¡µåº¯È¯°è¼ö
somatotropin release inhibiting factor
¼ºÀåÈ£¸£¸óºÐºñ¾ïÁ¦ÀÎÀÚ
spreading factor
È®»êÀÎÀÚ
stable factor
¾ÈÁ¤ÀÎÀÚ
scatter factor
»ê¶õ°è¼ö
stroma factor
¹öÆÀÁúÀÎÀÚ, °£ÁúÀÎÀÚ
sunprotective factor
Àϱ¤º¸È£Áö¼ö
sebotropic factor
Áö·çÃËÁøÀÎÀÚ
safety factor
¾ÈÀü°è¼ö
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
9
¿µ¹®
ÇѱÛ
spreading factor
È®»êÀÎÀÚ
stable factor
¾ÈÁ¤ÀÎÀÚ
stroma factor
¹öÆÀÁúÀÎÀÚ
sunprotective factor
Àϱ¤º¸È£Áö¼ö
testis-determining factor
°íȯ°áÁ¤ÀÎÀÚ
therapeutic gain factor
Ä¡·áÀ̵æ°è¼ö
thyrotrophin releasing factor
¹æÆÐ»ùÀÚ±ØÈ£¸£¸óÀ¯¸®ÀÎÀÚ, °©»ó»ùÀÚ±ØÈ£¸£¸óÀ¯¸®ÀÎÀÚ
time-dose factor
½Ã°£¼±·®ÀÎÀÚ
tissue factor
Á¶Á÷ÀÎÀÚ
transfer factor
Àü´ÞÀÎÀÚ
transforming growth factor
Àüȯ¼ºÀåÀÎÀÚ
transmission factor
Åõ°ú°è¼ö
tumor angiogenesis factor
Á¾¾çÇ÷°üÇü¼ºÀÎÀÚ
tumor necrosis factor
Á¾¾ç±«»çÀÎÀÚ
vascular endothelial growth factor
Ç÷°ü³»ÇǼºÀåÀÎÀÚ
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
9
¿µ¹®
ÇѱÛ
predisposing factor
¼ÒÀμº ¿äÀÎ, ¼±Çà¿äÀÎ.
prognostic factor
¿¹ÈÄÀÎÀÚ
prolactin inhibiting factor
ÇÁ·Ñ¶ôƾ(ºÐºñ)¾ïÁ¦ÀÎÀÚ.
prolactin inhibiting factor
ÇÁ·Î¶ôƾ¾ïÁ¦ÀÎÀÚ
prolactin-inhibitory factor(PIF)
ÇÁ·Î¶ôƾ ºÐºñ ¾ïÁ¦ ÀÎÀÚ
prolactin-releasing factor(PRF)
ÇÁ·Î¶ôƾ ºÐºñ À¯¹ß ÀÎÀÚ
protein synthesis factor
´Ü¹éÇÕ¼ºÀÎÀÚ(Ó±ÛÜùêà÷ì×í).
psychogenic factor
½ÉÀμº ¿ä¼Ò(¡é©áÈ).
psychological factor
½É¸®Àû ¿äÀÎ
psychosocial factor
½É¸®»çȸÀû ¿äÀÎ
quality factor
Á¤¼ºÀÎÀÚ(ïÒàõì×í).
quality factor
¼±Áú°è¼ö
radiation weighting factor
¹æ»ç¼±°¡Áß°è¼ö
realization factor
½ÇÇöÀÎÀÚ(ãùúÞì×í).
recruitment factor
´©°¡¿äÀÎ(׫ʥé©ì×).
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
9
¿µ¹®
ÇѱÛ
endothelium-derived relaxing factor
³»ÇǼ¼Æ÷¼º ÀÌ¿ÏÀÎÀÚ(¡ì¬èÐì×í).
endothelium-derived relaxing factor
³»ÇÇ ¼¼Æ÷¼º ÀÌ¿ÏÀÎÀÚ
endothelium-derived relaxing factor (EDRF)
³»ÇǼ¼Æ÷¼ºÀÌ¿ÏÀÎÀÚ
endurance factor =EF
Áö¼ÓÀÎÀÚ(ò¥áÙì×í).
environmental chemotactic factor
ȯ°æ¼ºÈÇÐÁÖ¼ºÀÎÀÚ(ü»ÌÑàõûùùÊñËàõì×í)
environmental factor
ȯ°æÀÎÀÚ.
eosinophil chemotactic factor
È£»ê±¸ ÈÇÐÁÖ¼ºÀÎÀÚ
eosinophil chemotactic factor =ECF
È£»ê±¸ ÈÇÐÁÖ¼ºÀÎÀÚ.
eosinophilic chemotactic factor
È£»ê±¸¼º ÈÇÐÁÖ¼ºÀÎÀÚ
epidermal growth factor
Ç¥ÇǼºÀåÀÎÀÚ
epidermal growth factor
Ç¥ÇǼºÀåÀÎÀÚ(øúù«à÷íþì×í)
epidermal growth factor
Ç¥ÇǼºÀå ÀÎÀÚ(¡à÷íþ ì×í)
epidermal growth factor (EGF)
ÇǺÎÁõ½ÄÀÎÀÚ
epidermal growth factor = EGF
Ç¥ÇÇ ¼ºÀå ÀÎÀÚ
epidermoid growth factor
Ç¥ÇÇ¾ç ¼ºÀåÀÎÀÚ(¡à÷íþì×í)
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
9
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
9
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
9
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
9
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
9
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
9
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½